The BHF claims women are less likely than men to seek medical attention when experiencing a cardiac episode.

The company has received clearance from the US FDA to start an open-label Phase I trial for RespiRx nicotine inhaler in ...

SetPoint has already reported positive topline results for the trial in a separate study in rheumatoid arthritis.

ProJenX and Unlearn partnered to implement genAI technology for a Phase I trial of prosetin for amyotrophic lateral sclerosis ...

On 26 September 2024, Bristol Myers Squibb (BMS) announced that the US Foof and Drug Administration approved Cobenfy ...

Muscle-sparing is particularly important in patients with heart failure as it is associated with higher mortality.

Johnson & Johnson has reported Phase III data where CARVYKTI improved overall survival in patients with multiple myeloma.

The retrospective study presented at ESMO 2024 involved about 2,400 patients with stage 3 or 4 non-small cell lung cancer.

Moderna has dosed the first subject in the US in its Phase III Nova 301 clinical trial of its investigational norovirus vaccine, mRNA-1403.

Longboard Pharmaceuticals has commenced the Phase III DEEp SEA Study of bexicaserin for treating seizures in Dravet syndrome ...

An NHS paediatrician sent a WhatsApp message offering children and parents £1,500 to take part in Moderna’s Phase III ...

IDEAYA Bioscience’s rare cancer drug shows benefit in interim Phase II data, with the company announcing the drugs Phase III ...